loading
Precedente Chiudi:
$0.6614
Aprire:
$0.652
Volume 24 ore:
79,705
Relative Volume:
0.27
Capitalizzazione di mercato:
$21.85M
Reddito:
-
Utile/perdita netta:
$-98.79M
Rapporto P/E:
-0.2023
EPS:
-3.27
Flusso di cassa netto:
$-51.66M
1 W Prestazione:
+7.98%
1M Prestazione:
+2.27%
6M Prestazione:
+139.72%
1 anno Prestazione:
-75.68%
Intervallo 1D:
Value
$0.6283
$0.6614
Intervallo di 1 settimana:
Value
$0.59
$0.6614
Portata 52W:
Value
$0.2404
$3.98

Relmada Therapeutics Inc Stock (RLMD) Company Profile

Name
Nome
Relmada Therapeutics Inc
Name
Telefono
646 876 3459
Name
Indirizzo
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, NY
Name
Dipendente
17
Name
Cinguettio
@relmada
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
RLMD's Discussions on Twitter

Confronta RLMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
3.03 0 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
1.40 1.80B 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.48 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.66 117.56M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.4869 337.18M 2.07B -1.42B -1.37B -0.6765
 icon
DAVEW
Dave Inc
1.25 0 0 0 0 0.00

Relmada Therapeutics Inc Stock (RLMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-05 Downgrade Mizuho Outperform → Neutral
2024-09-17 Aggiornamento Jefferies Hold → Buy
2024-06-05 Downgrade Goldman Neutral → Sell
2022-10-14 Downgrade Goldman Buy → Neutral
2022-10-14 Downgrade Guggenheim Buy → Neutral
2022-10-14 Downgrade Truist Buy → Hold
2022-10-13 Downgrade Oppenheimer Outperform → Perform
2021-11-18 Iniziato Mizuho Buy
2021-05-20 Ripresa Goldman Buy
2020-10-28 Downgrade Goldman Buy → Neutral
2020-07-14 Iniziato Oppenheimer Outperform
2020-05-04 Iniziato SunTrust Buy
2020-04-21 Iniziato Goldman Buy
2020-01-27 Iniziato Jefferies Buy
2020-01-10 Iniziato SVB Leerink Outperform
2019-12-16 Iniziato Guggenheim Buy
Mostra tutto

Relmada Therapeutics Inc Borsa (RLMD) Ultime notizie

pulisher
03:39 AM

Best data tools to analyze Relmada Therapeutics Inc. stockGap Up & Fast Entry Momentum Trade Alerts - Newser

03:39 AM
pulisher
02:26 AM

Advanced analytics toolkit walkthrough for Relmada Therapeutics Inc.July 2025 Drop Watch & Low Drawdown Trading Techniques - Newser

02:26 AM
pulisher
Aug 26, 2025

Analyzing Relmada Therapeutics Inc. with multi timeframe chartsWeekly Gains Report & Smart Money Movement Tracker - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Statistical indicators supporting Relmada Therapeutics Inc.’s strengthTrade Performance Summary & Growth Focused Stock Pick Reports - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Price momentum metrics for Relmada Therapeutics Inc. explained2025 Sector Review & Fast Moving Stock Watchlists - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Market reaction to Relmada Therapeutics Inc.’s recent news2025 Bull vs Bear & Stock Portfolio Risk Control - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

What MACD signals say about Relmada Therapeutics Inc.Quarterly Growth Report & AI Forecast for Swing Trade Picks - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Is a relief rally coming for Relmada Therapeutics Inc. holdersQuarterly Portfolio Report & Long-Term Investment Growth Plans - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Chartists See Breakout Potential in Relmada Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 26, 2025
pulisher
Aug 26, 2025

Relmada Therapeutics Inc. stock trend outlook and recovery path2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Using AI based signals to follow Relmada Therapeutics Inc.July 2025 Patterns & Intraday High Probability Setup Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

How to integrate Relmada Therapeutics Inc. into portfolio analysis toolsWeekly Trade Report & Verified Technical Trade Signals - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

What data driven models say about Relmada Therapeutics Inc.’s futureQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Should you wait for a breakout in Relmada Therapeutics Inc.July 2025 Reactions & Accurate Buy Signal Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Tools to assess Relmada Therapeutics Inc.’s risk profileJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Evaluating Relmada Therapeutics Inc. with trendline analysisMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

What’s next for Relmada Therapeutics Inc. stock pricePortfolio Update Summary & Entry Point Strategy Guides - Newser

Aug 25, 2025
pulisher
Aug 25, 2025

Relmada Therapeutics Inc. stock momentum explainedEarnings Risk Summary & Short-Term Trading Alerts - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Is it too late to sell Relmada Therapeutics Inc.July 2025 Market Mood & High Yield Stock Recommendations - Newser

Aug 24, 2025
pulisher
Aug 24, 2025

Is Relmada Therapeutics Inc.’s growth already priced inJuly 2025 Momentum & Low Drawdown Investment Ideas - sundaytimes.kr

Aug 24, 2025
pulisher
Aug 23, 2025

Published on: 2025-08-23 21:25:05 - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

What is Relmada Therapeutics Inc. s revenue forecastWeekly Earnings Recap & Risk Managed Trade Strategies - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 23, 2025

Published on: 2025-08-23 18:28:07 - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Is it time to cut losses on Relmada Therapeutics Inc.Trade Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Aug Catalysts: Can Relmada Therapeutics Inc. maintain its current growth rateEarnings Risk Report & Fast Gaining Stock Strategy Reports - theviewers.co.kr

Aug 23, 2025
pulisher
Aug 22, 2025

Will Relmada Therapeutics Inc. benefit from macro trendsJuly 2025 Spike Watch & Precise Swing Trade Entry Alerts - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

Machine Learning Models Forecast Relmada Therapeutics Inc. UptickPortfolio Return Summary & Consistent Profit Trade Alerts - kangso.co.kr

Aug 22, 2025
pulisher
Aug 22, 2025

Why Relmada Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Rallies & Daily Profit Maximizing Tips - beatles.ru

Aug 22, 2025
pulisher
Aug 20, 2025

Recovery Setup Building in Relmada Therapeutics Inc. Experts SayQuarterly Market Review & Community Shared Stock Ideas - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

When is the best time to exit Relmada Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Is Relmada Therapeutics Inc. a candidate for recovery playTrade Analysis Report & Reliable Entry Point Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Will Relmada Therapeutics Inc. price bounce be sustainable2025 Biggest Moves & Precise Buy Zone Identification - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Order flow analysis tools used on Relmada Therapeutics Inc.Trade Ideas & Risk Managed Investment Entry Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Using fundamentals and technicals on Relmada Therapeutics Inc.2025 Analyst Calls & AI Driven Price Predictions - Newser

Aug 18, 2025

Relmada Therapeutics Inc Azioni (RLMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Relmada Therapeutics Inc Azioni (RLMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Shenouda Maged
Chief Financial Officer
May 19 '25
Buy
0.49
90,000
43,686
228,335
Shenouda Maged
Chief Financial Officer
May 20 '25
Buy
0.52
60,000
31,422
288,335
Shenouda Maged
Chief Financial Officer
May 16 '25
Buy
0.44
50,000
22,100
138,335
Ence Chuck
CA and CO
May 16 '25
Buy
0.45
228,961
103,330
267,931
TRAVERSA SERGIO
Chief Executive Officer
May 20 '25
Buy
0.56
147,686
82,246
734,024
TRAVERSA SERGIO
Chief Executive Officer
May 16 '25
Buy
0.45
172,314
77,472
556,338
TRAVERSA SERGIO
Chief Executive Officer
May 19 '25
Buy
0.50
30,000
14,994
586,338
TRAVERSA SERGIO
Chief Executive Officer
Sep 11 '24
Buy
2.99
51,407
153,707
384,024
TRAVERSA SERGIO
Chief Executive Officer
Sep 09 '24
Buy
2.71
55,579
150,619
299,603
TRAVERSA SERGIO
Chief Executive Officer
Sep 10 '24
Buy
2.75
33,014
90,788
332,617
$24.63
price up icon 0.24%
$84.63
price up icon 0.77%
$24.70
price down icon 8.71%
$103.63
price down icon 0.75%
$132.87
price up icon 0.61%
biotechnology ONC
$300.48
price down icon 2.95%
Capitalizzazione:     |  Volume (24 ore):